L. casei CCFM419 had a potential ability to ameliorate insulin resistance and hyperglycemia in T2DM mice through underlying PI3K/Akt signaling pathway and gut flora-SCFAs-inflammation/GLP-1 mechanism (105, 106). The gene discussed is AKT1; the disease is type 2 diabetes mellitus.